The Effect of Continuous Midwifery-led Care in Birth Management
The Effect of Midwife-Led Care on Perception of Labour Pain, Duration of Labour, Comfort of Labour and Respectful Maternity Care: a Single Blinded Randomised Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mardin, Turkey
- Mardin Nusaybi̇N State Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant women with spontaneous pregnancy between 38-42 weeks of gestation
- single fetus head presentation
- first pregnancy
- without any pregnancy-related risk status (such as preeclampsia, gestational diabetes)
- who were admitted to the delivery room for normal labour will be included in the study.
Exclusion Criteria:
- WOMEN WHO CANNOT GIVE BIRTH NORMALLY
- WANT TO LEAVE THE LABOUR FORCE
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Receiving midwife-led care
The birth process will be followed by the same midwife from the beginning of the intrapartum period until the birth of the baby and placenta.
In this process, positive respectful maternal care will be included in line with the recommendations of WHO (İsbir & Sercekuş, 2017).
|
The birth process will be followed by the same midwife from the beginning of the intrapartum period until the birth of the baby and placenta.
In this process, positive respectful maternal care will be included in line with the recommendations of WHO (İsbir & Sercekuş, 2017).
|
|
No Intervention: Midwife-Led Non-Care Receiving Care
Participants in the group will receive routine care normally provided only in the hospital.
Within this care, from the beginning of the intrapartum period until the birth of the baby and placenta, the birth process will be followed under the supervision of a midwife or physician who is randomly available within the working conditions of the birth unit.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Effect of Midwife-Led Care on Perception of Labour Pain, Duration of Labour, Comfort of Birth and Respectful Maternity Care
Time Frame: 1 years
|
Measurement Tools Information Form (IF) (Appendix 1): This form was prepared in line with the literature (Liu et al., 2021) and includes socio-demographic and obstetric characteristics of the participants.
|
1 years
|
|
Birth Pain
Time Frame: 1 years
|
Visual Analog Scale (VAS) (ANNEX-2): The Visual Analog Scale (VAS) was developed by Price et al. in 1983 and is used to measure pain intensity and for pain monitoring.
The VAS is 10 cm long and the two ends are named differently.
On the scale, '0' indicates no pain and '10' indicates the most severe level of pain.
The VAS is a measurement tool that is frequently and reliably used to assess labor pain (Price et al., 1983; Mutlu & Özkaya, 2021).
|
1 years
|
|
birth monitoring
Time Frame: 1 years
|
Birth Monitoring Form (DIF) (ANNEX-3) : It was aimed to evaluate the labour process with the labour monitoring form developed by the researchers.
In the birth follow-up form, data obtained from pregnant women in G1 and G2 regarding cervical dilatation and dilatation, duration, frequency and intensity of contractions, time of delivery, and time of placental separation will be recorded.
|
1 years
|
|
Comfort of Birth
Time Frame: 1 years
|
Birth Comfort Scale (BCS) (ANNEX-4): It was developed by Kerri Durnell Schuiling in 2003, inspired by Kolcaba's comfort theory.
The original version consists of fourteen items.
The scale is a five-point Likert-type scale (1= Strongly disagree, 5= Strongly agree).
Its Turkish validity and reliability was performed by Potur et al.
There are three subscales/factors (environmental, physical, psychospiritual) in the Turkish version of the comfort of labour scale consisting of nine items.
Items 2,3,4,6 of the scale are divided into sub-dimensions in the physical dimension, items 7,8 in the psychospiritual dimension and items 1,5,9 in the environmental dimension.
A minimum of 9 and a maximum of 45 points can be obtained from the scale.
The Cronbach Alpha value of the scale was found to be 0.75 (Potur et al., 2015).
|
1 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respectful Maternity Care
Time Frame: 1 years
|
Respectful Motherhood Care Scale (RMCS) (ANNEX-5): The scale was developed by Dişsiz et al. in 2023.
With the five-point Likert-type scale, it was aimed to evaluate the respectful maternity care perceived by women between the 6th week and 1 year postpartum during pregnancy, birth and postpartum period.
The scale consists of a total of 29 items and 3 sub-dimensions with mixed positive and negative statements.
The sub-dimensions are 'Consensual Dignified Care (17 items)', 'Psychological Abuse and Care Neglect (7 items)' and 'Physical Violence, Privacy Violation and Discrimination (5 items)'.
The highest total score that can be obtained from the scale is 145 and the lowest score is 29.
An increase in the score obtained from the overall scale indicates that the woman's perception that she received respectful maternity care during pregnancy, birth and postpartum period increased, while a decrease indicates that the woman's perception that she received respectful maternity care during pregn
|
1 years
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2023/1191
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.